Moderna and Merck will jointly develop and sell a cancer vaccine that is personalized for individual patients, the companies announced on Wednesday.
Moderna's experimental vaccine...
COVID-19 vaccines using mRNA technology do not produce any extra short-term side effects in cancer patients, a new study suggests.
Researchers surveyed 1,753 recipients of...
Combining AstraZeneca’s COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna’s jab provides “good protection”, Denmark’s State Serum Institute said on Monday.
A...
GENEVA: The benefits of mRNA COVID-19 vaccines outweigh the very small risk they might cause heart inflammation, as the jabs reduce hospitalisations and deaths,...
Ten days after receiving a second dose of the messenger RNA (mRNA) vaccines people without COVID-19 symptoms are far less likely to be carrying the virus